Management of Hyperprolactinemia Caused by Pituitary Microadenoma

Authors

  • Ibnu Muttaqin Department of Obstetry and Gynecology, Faculty of Medicine, Andalas University/Dr. M. Djamil, Padang
  • Haviz Yuad Subdivision of Fertility and Endocrynology, Department of Obstetry and Gynecology, Faculty of Medicine, Andalas University/Dr. M. Djamil, Padang

DOI:

https://doi.org/10.25077/aoj.8.1.642-647.2024

Keywords:

Hyperprolactionemia, Pituitary microadenoma, Secondary amenorrhea

Abstract

Hyperprolactinemia is an increase in fasting levels of the hormone prolactin above 20 ng/ml in men and above 25 ng/ml in women. Hyperprolactinemia occurs more often in women of reproductive age, with a percentage of 9 – 17%. The etiology of hyperprolactinemia can occur due to abnormal pituitary secretions, systemic disease, use of drugs, damage to the hypothalamus-pituitary axis. A 33-year old female patient came to the FER Polyclinic at M. Djamil Hospital with complaints of not menstruating for the past 2 months. Irregular menstruation since 15 years ago, menstruation 2-3 times in 6 months, irregular cycle for 7-8 days. The patient also complained of a fluid like breast milk coming out of the breast for 5 years, initially the fluid came out in a trickle and then gradually reduced and now the fluid comes out occasionally if the breast is squeezed. From the supporting examinations carried out, it was found that the prolactin hormone level in this patient was 134.53, and the results of the MRI examination showed a mass measuring 1.05x1.12x0.5 mm, which was diagnosed as secondary amenorrhea, hyperprolactinemia, and suspected pituitary microadenoma. The patient will be monitored for general condition and vital signs, as well as consultations with colleagues involved, such as consultations to the Internal Medicine section, Endocrinology, Metabolic and Diabetes Subdivision.

Author Biographies

Ibnu Muttaqin, Department of Obstetry and Gynecology, Faculty of Medicine, Andalas University/Dr. M. Djamil, Padang

Department of Obstetry and Gynecology, Faculty of Medicine, Andalas University/Dr. M. Djamil,

Padang

Haviz Yuad, Subdivision of Fertility and Endocrynology, Department of Obstetry and Gynecology, Faculty of Medicine, Andalas University/Dr. M. Djamil, Padang

Subdivision of Fertility and Endocrynology, Department of Obstetry and Gynecology, Faculty of

Medicine, Andalas University/Dr. M. Djamil, Padang

References

Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci. 2013;6(3):168-175.

doi:10.4103/0974-1208.121400

Molitch ME, Drummond J, Korbonits M. A Service of the National Library of Medicine.

MDText.com, Inc; 2012.

Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: An

endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism.

;96(2):273-288. doi:10.1210/jc.2010-1692

Wang AT, Mullan RJ, Lane MA, et al. Treatment of hyperprolactinemia: A systematic review and

meta-analysis. Syst Rev. 2012;1(1). doi:10.1186/2046-4053-1-33

Vroonen L, Daly AF, Beckers A. Epidemiology and Management Challenges in Prolactinomas.

Neuroendocrinology. 2019;109(1):20-27. doi:10.1159/000497746ed

Molitch ME. Diagnosis and treatment of pituitary adenomas: A review. JAMA - Journal of the

American Medical Association. 2017;317(5):516-524. doi:10.1001/jama.2016.19699

Downloads

Published

2024-01-30

Issue

Section

CASE REPORT